Baxter International is a US company operating worldwide in the pharmaceutical and medical technology sectors. The company produces drugs for anesthesiology and intensive care medicine, vaccines and medical devices.
P/E ratio for Baxter (BAX)
P/E ratio as of April 2023 (TTM): -8.39
According to Baxter's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -8.38716. At the end of 2021 the company had a P/E ratio of 33.5.
P/E ratio history for Baxter from 2001 to 2022
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2021 | 33.5 | -9.74% |
| 2020 | 37.1 | |
| 2018 | 21.7 | -55.79% |
| 2017 | 49.0 | |
| 2015 | 21.5 | 148.79% |
| 2014 | 8.65 | -15.24% |
| 2013 | 10.2 | 19% |
| 2012 | 8.58 | 24.82% |
| 2011 | 6.87 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Medtronic MDT | 26.4 | -414.71% | 🇮🇪 Ireland |
 Thermo Fisher Scientific TMO | 32.5 | -486.97% | 🇺🇸 USA |
 Becton Dickinson BDX | 46.4 | -653.11% | 🇺🇸 USA |
 Boston Scientific BSX | 111 | -1,424.78% | 🇺🇸 USA |
 Stryker Corporation SYK | 45.8 | -645.69% | 🇺🇸 USA |
 Cardinal Health CAH | -16.3 | 94.42% | 🇺🇸 USA |
 ICU Medical
ICUI | -52.9 | 530.71% | 🇺🇸 USA |
 Halozyme Therapeutics HALO | 25.8 | -407.54% | 🇺🇸 USA |
 Owens & Minor
OMI | 46.9 | -659.42% | 🇺🇸 USA |
 CryoLife CRY | N/A | N/A | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.